Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells

Area of Science:

• Neuro-oncology
• Developmental Neuroscience
• Cancer Biology

Background:

• Group 3 medulloblastoma (MB_G3) is a pediatric brain tumor with poor prognosis.
• Existing MB_G3 models lack physiological relevance, limiting research into cellular origins.
• MYC amplification/overexpression is common in MB_G3, correlating with metastasis and dismal outcomes.

Purpose of the Study:

• To develop physiologically relevant MB_G3 mouse models.
• To investigate the cellular origin of MB_G3 within the developing cerebellum.
• To understand how oncogenic insults contribute to MB_G3 development.

Main Methods:

• In utero electroporation in mouse models.
• Conditional expression of Myc and loss of Trp53 function using Cre driver lines (e.g., Blbp-Cre).
• Co-expression of luciferase for tumor tracking and analysis of distinct cerebellar progenitor cells.

Main Results:

• MB_G3 mouse models were successfully developed in situ, recapitulating human MB_G3 histopathology.
• Both GABAergic neuronal progenitors and cerebellar granule cells were identified as cellular origins for MB_G3.
• Gene expression analysis confirmed molecular similarities between novel mouse models and human MB_G3, regardless of cell origin.

Conclusions:

• Oncogenic insults can drive MB_G3 development across different cerebellar lineages, not from a single specific cell type.
• Developed MB_G3 mouse models provide valuable tools for studying tumor development and therapeutic strategies.
• Findings challenge the notion of a singular cell of origin for MB_G3, suggesting broader lineage susceptibility.